中国房颤人群心肌组织中MMPs与TIMPs的mRNA表达水平的Meta分析

doi:10.6040/j.issn.1671-7554.0.2014.485

摘要/Abstract

摘要： 目的探讨心肌组织中MMPs、TIMPs的 mRNA表达水平与中国房颤人群的相关性。方法检索2001年1月至2014年5月Pubmed, Web of Science, CNKI和万方数据库已发表文献,研究人群为经心脏外科手术的中国房颤与窦性心律患者,取左右心房或左右心耳的心肌组织,检测MMPs和TIMPs的mRNA表达水平在房颤组与窦性心律组的差别。结果纳入9篇文献,通过荟萃分析发现,MMP-1的mRNA表达水平房颤组较窦性心律组明显增加(SMD=0.48, 95% CI:0.20~0.76, P<0.01)。MMP-9的mRNA表达水平房颤组较窦性心律组明显增加(SMD=1.11, 95% CI:0.75~1.46, P<0.01)。TIMP-1的mRNA表达水平房颤组较窦性心律组无明显差异(SMD=-0.56, 95% CI:-1.77~0.65, P=0.37)。TIMP-2的mRNA表达水平房颤组较窦律组无明显差异(SMD=0.31, 95% CI: -1.16~1.78, P=0.68)。结论心房纤维化在房颤的发生和维持发挥着重要作用,基质金属蛋白酶中MMP-1和MMP-9影响心房的纤维化,其转录水平的升高促进房颤的发生,参与房颤的心房结构重构,而TIMPs在房颤中的作用尚存争议。

关键词: 房颤, 基质金属蛋白酶, 基质金属蛋白酶组织抑制剂

Abstract: Objective To explore the correlation between myocardial MMPs and TIMPs mRNA levels and Chinese with atrial fibrillation (AF). Methods Databases including Pubmed, Web of Science, CNKI and Wanfang were searched up to May, 2014, to retrieve published studies comparing myocardial mRNA levels of MMPs and TIMPs in Chinese AF patients and sinus rhythm (SR) patients, and then a meta-analysis was conducted. The cardiac tissue samples were obtained from patients who underwent cardiac surgery. Results Altogether 9 studies with AF patients and SR controls were included. The MMP-1 mRNA expression was higher in AF patients than in controls (SMD=0.48, 95% CI: 0.20 to0.76, P<0.01). The MMP-9 mRNA expression was higher in AF patients than in controls (SMD=1.11, 95% CI: 0.75 to 1.46, P<0.01). There was no significant difference in the TIMP-1 and TIMP-2 mRNA expressions between AF patients and controls (SMD=-0.56, 95% CI:-1.77 to 0.65, P=0.37), (SMD=0.31, 95% CI:-1.16 to 1.78, P=0.68). Conclusion Atrial fibrosis increases in atrial fibrillation, and the increased transcript levels of MMP-1 and MMP-9 are associated with the occurrence of atrial fibrillation and remodeling of atrial structure. However, the role of TIMPs is still unclear.

Key words: Matrix metalloproteinases, Atrial fibrillation, Tissue inhibitors of matrix metalloproteinases

中图分类号:

R541

张伶俐, 周莹, 李小荷, 李慧, 钟明, 张薇. 中国房颤人群心肌组织中MMPs与TIMPs的mRNA表达水平的Meta分析[J]. 山东大学学报（医学版）, 2015, 53(1): 47-53.

ZHANG Lingli, ZHOU Ying, LI Xiaohe, LI Hui, ZHONG Ming, ZHANG Wei. Myocardial MMPs and TIMPs mRNA expressions in Chinese population with atrial fibrillation: a Meta-analysis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(1): 47-53.

参考文献

[1] Khairy P, Nattel S. New insights into the mechanisms and management of atrial fibrillation[J]. CMAJ, 2002, 167(9):1012-1020.
[2] van den Berg MP, van Gelder IC, van Veldhuisen DJ. Impact of atrial fibrillation on mortality in patients with chronic heart failure[J]. Eur J Heart Fail, 2002, 4(5):571-575.
[3] Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation [J]. Cardiovasc Res, 2002, 54(2):230-246.
[4] Brundel BJ, Henning RH, Kampinga HH, et al. Molecular mechanisms of remodeling in human atrial fibrillation [J]. Cardiovasc Res, 2002, 54(2):315-324.
[5] Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation[J]. Circulation, 2004, 109(3):363-368.
[6] Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease[J]. Biochem Pharmacol, 2008, 75(2):346-359.
[7] Clark IM, Swingler TE, Sampieri CL, et al. The regulation of matrix metalloproteinases and their inhibitors [J]. Int J Biochem Cell Biol, 2008, 40(6-7):1362-1378.
[8] Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy[J]. Circulation, 1998, 97(17):1708-1715.
[9] Jeanine D Armiento. Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction[J]. Trends Cardiovasc Med, 2002, 12(3):97 -101.
[10] Gomez DE, Alonso DF, Yoshiji H, et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions [J]. Eur J Cell Biol, 1997, 74(2):111-122.
[11] Roten L, Nemoto S, Sinsic J, et al. Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice[J]. J Mol Cell Cardiol, 2000, 32(1): 109-120.
[12] Higgins JPT, Green S. Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions[M]. Chichester, England; Hoboken, NJ:Wiley-Blackwell, 2008.
[13] 柯丹, 许春萱, 张建成, 等. 心房颤动患者心房组织中明胶酶的基因表达及活性变化[J]. 中华心血管杂志, 2005, 33(2):137-142. KE Dan, XU Chunxuan, ZHANG Jiancheng, et al. Changes in gelatinases expression and activity in human atria during atrial fibrillation[J]. Chin J Cardiol, 2005, 33(2):137-142.
[14] 吕家高, 王岚, 陈运清, 等. 基质金属蛋白酶-1和基质金属蛋白酶-9及其抑制剂-1对心房颤动患者心房结构重构的影响[J]. 临床内科杂志, 2006, 23(4):276-278. LV Jiagao, WANG Lan, CHEN Yunqing, et al. Effects of matrix metalloproteinase-1,9 and tissue inhibitor-1 of metalloproteinase expression on human atrial structural remodeling during atrial fibrillation [J]. J Clin Intern Med, 2006, 23(4): 276-278.
[15] 许静, 吴冬燕, 毛用敏, 等. 基质金属蛋白酶表达和活性改变同心房颤动患者心房纤维化的关系[J]. 中华心律失常学杂志, 2006, 10(5):345-348. XU Jing, WU Dongyan, MAO Yongmin, et al. The relationship between atrial fibrosis and matrix metalloproteinases in human atria with atrial fibrillation [J]. Chin J Cardiac Arrhyth, 2006, 10(5):345-348.
[16] 王蔚, 吴平生, 杨希立. 基质金属蛋白酶及其抑制剂对心房颤动心房结构重构的影响[J]. 南方医科大学学报, 2010, 30(5):1160-1162. WANG Wei, WU Pingsheng, YANG Xili. Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation [J]. J South Med Univ, 2010, 30(5):1160-1162.
[17] 许国军, 甘天翔, 汤宝鹏, 等. 慢性房颤患者左右心房胶原和基质金属蛋白酶表达差异[J]. 生理学报, 2009, 61(3):211-216. XU Guojun, GAN Tianxiang, TANG Baopeng, et al. Differential expression of collagen and matrix metalloproteinases between left and right atria in patients with chronic atrial fibrillation[J]. Acta Physiologica Sinica, 2009, 61(3):211-216.
[18] 王蔚, 杨希立. 基质金属蛋白酶及脑利钠肽对心房颤动患者心房重构的影响[J]. 中国医药导报, 2012, 9(16):71-74. WANG Wei, YANG Xili. Effects of matrix metalloproteinase and B-type natriuretic peptide expression on atrial structural remodeling with atrial fibrillation [J]. China medical herald, 2012, 9(16):71-74.
[19] 陈运清, 王琳, 殷跃辉, 等. 基质金属蛋白酶-1,9和金属蛋白酶组织抑制因子-1对心房结构重构的作用[J]. 上海医学, 2008, 31(1):55-58. CHEN Yunqing, WANG Lin, YIN Yuehui, et al. Role of matrix metalloproteinases 1 and 9 and tissue inhibitor of metalloproteinase 1 in atrial structure remodeling[J]. Shanghai Med J, 2008, 31(1):55-58.
[20] 朱慧, 张薇, 郭辰虹, 等. 心房肌基质金属蛋白酶-9和组织金属蛋白酶抑制因子-1表达改变对房颤心房重构机制的研究[J]. 中华医学杂志, 2005, 85(1):45-48. ZHU Hui, ZHANG Wei, GUO Chenhong, et al. Differential gene expression during atrial structural remodeling in human left and right atrial appendages in atrial fibrillation [J]. National Medical Journal of China, 2005, 85(1):45-48.
[21] 甘天翔, 汤宝鹏. 心脏瓣膜病慢性房颤患者心房肌间质纤维化分子机制研究[D]. 乌鲁木齐: 新疆医科大学, 2009.
[22] 薛邦德, 周华富. 心房肌MMP-2及TIMP-2的表达改变对风心患者房颤心房结构重构机制的研究[D]. 南宁: 广西医科大学, 2008.
[23] Davies MJ, Pomerance A. Pathology of atrial fibrillation in man [J]. Br Heart J, 1972, 34(5):520-525.
[24] Everett TH 4th, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm, 2007, 4(3suppl):24-27.
[25] Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients[J]. Cardiovasc Res, 2002, 54(2):361-379.
[26] Xu J, Cui G, Esmailian F, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation[J]. Circulation, 2004, 109(3):363-368.
[27] Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function[J]. Physiol Rev, 2007, 87(4):1285-1342.
[28] Marchesi C, Dentali F, Nicolini E, et al. Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis [J]. J Hypertens, 2012, 30(1):3-16.
[29] 戴天医, 刘小慧. 基质金属蛋白酶/基质金属蛋白酶组织抑制剂与心房颤动[J]. 心血管病学进展, 2012, 33(2):185-188. DAI Tianyi, LIU Xiaohui. Matrix Metalloproteinases, Tissue Inhibitor of Metalloproteinases and Atrial Fibrillation[J]. Adv Cardiovasc Dis, 2012, 33(2):185-188.
[30] 季芳, 张艳. 心肌的金属基质蛋白酶表达对房颤心肌重构的影响[J]. 辽宁中医药大学学报, 2007, 9(3):81-83. JI Fang, ZHANG Yan. Expression of Matrix Metalloproteinases in Myocardium Contributes To Human Myocardial Remodeling during Atrial Fibrillation [J]. Journal of Liaoning University of TCM, 2007, 9(3):81-83.
[31] Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation[J]. Cell Mol Life Sci, 2008, 65(10):1489-1508.
[32] Hinton RB,Yutzey KE. Heart valve structure and function in development and disease[J]. Annu Rev Physiol, 2011, 73:29-46.
[33] 隋玺仲, 高长青. 基质金属蛋白酶及其抑制剂在风湿性二尖瓣狭窄合并心房纤颤中的作用[J]. 解放军医学院学报, 2014, 35(5):500-502. SUI Xizhong, GAO Changqing. Effect of matrix metalloproteinases and tissue inhibitors of metalloproteinases on rheumatic mitral valve stenosis with atrial fibrillation [J]. Acad J Chin PLA Med Sch, 2014, 35(5):500-502.

相关文章 15

[1]	魏金秋,张玉娇,李展,王曦敏,陈琳琳,杜娟娟,张勇,解新星,侯应龙. GCH1通过BH4通路对快速心房起搏犬自主神经重构的影响[J]. 山东大学学报（医学版）, 2017, 55(5): 8-12.
[2]	宋昱,毛洋,刘庆梅,乔磊,帖媛媛,鲁璐,张蕾. 通心络对兔腹主动脉粥样硬化易损斑块中三维应变的影响[J]. 山东大学学报（医学版）, 2017, 55(5): 1-7.
[3]	李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 49-55.
[4]	樊彦伟,严冬雪,招友. 富氢水对兔腰椎间盘退变的影响[J]. 山东大学学报（医学版）, 2017, 55(3): 38-42.
[5]	王伟,曹煜姗,孙达权,黄小琼,徐国强. 人TIMP-2蛋白在肝癌细胞迁移与侵袭中的作用[J]. 山东大学学报（医学版）, 2016, 54(7): 11-17.
[6]	巨媛媛,任满意,李睿,赵萌萌,隋树建. TWEAK通过ERK1/2通路促进大鼠心肌成纤维细胞MMP2与Ⅰ型胶原表达[J]. 山东大学学报（医学版）, 2016, 54(5): 23-28.
[7]	徐延杰,崔谊,李红霞,史文琦,李福艳,王建震,曾庆师. X线照射对U87胶质瘤多细胞球体MMP-2活性及Cho/Cr的影响[J]. 山东大学学报（医学版）, 2016, 54(4): 6-10.
[8]	吕树卿, 尉蔚, 张灿灿, 田永杰. HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报（医学版）, 2015, 53(7): 1-7.
[9]	张凯, 梁飞, 韩波, 马晓春, 朱小龙, 张军, 张涛, 邹承伟. 同期射频消融改良迷宫Ⅲ术+心脏神经节丛消融术与单纯射频消融改良迷宫Ⅲ术治疗合并风湿性二尖瓣病变的心房颤动比较[J]. 山东大学学报（医学版）, 2015, 53(5): 66-70.
[10]	于磊, 李振. 白细胞介素33在脑血管病患者血清中的表达及其作用机制[J]. 山东大学学报（医学版）, 2015, 53(4): 75-79.
[11]	李曼, 钟敬泉, 岳欣, 朱清, 郑兆通, 荣冰, 衣少雷, 谢飞, 张运. 环肺静脉电隔离术的不同消融终点对房颤患者预后的影响[J]. 山东大学学报（医学版）, 2015, 53(3): 62-68.
[12]	张风雷, 郑曼, 张琦, 顾磊, 徐新生. 代谢综合征与P波离散度关系的探讨[J]. 山东大学学报（医学版）, 2015, 53(2): 52-55.
[13]	吕岩红, 高海青, 邱洁. 达比加群酯预防非瓣膜性房颤患者血栓栓塞的有效性和安全性[J]. 山东大学学报（医学版）, 2015, 53(11): 37-40.
[14]	涂燕, 李振江, 汤爱平, 费妍, 李慧慧, 李剑, 贺文凤. 干扰CD147表达抑制白血病细胞SHI-1增殖及移行[J]. 山东大学学报（医学版）, 2014, 52(9): 1-5.
[15]	李丛, 王建春, 赵勇, 邹承伟, 孙慧, 张庆. 瓣膜病患者钙调神经磷酸酶-活化T细胞核因子通路与心房纤颤的关系[J]. 山东大学学报（医学版）, 2014, 52(8): 47-51.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed